Abeona Therapeutics Inc. Common Stock

ABEO

...

ABEO: Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.

Show ABEO Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of ABEO by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by ABEO's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on ABEO's company Twitter account

WallStreetBets

Number of mentions of ABEO in WallStreetBets Daily Discussion

ABEO News

Recent insights relating to ABEO

CNBC Recommendations

Recent picks made for ABEO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ABEO

Corporate Flights

Flights by private jets registered to ABEO